Monitoring of Minimal Residual Disease in Multiple Myeloma After Allo-Sct: Flow Cytometry vs PCR-based Techniques

Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2008.14
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Flow Cytometry in the Diagnosis and Monitoring of Minimal Residual Disease in Multiple Myeloma

Oncogematologiya
OncologyHematology
2017English

Prospective Trial of Minimal Residual Disease Assessment by Multiparametric Flow Cytometry for Multiple Myeloma in the Era of Bortezomib-Based Chemotherapy

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Prospective Molecular Monitoring of Minimal Residual Disease After Non-Myeloablative Allografting in Newly Diagnosed Multiple Myeloma

Blood
BiochemistryImmunologyCell BiologyHematology
2014English

Minimal Residual Disease Testing After Stem Cell Transplantation for Multiple Myeloma

Bone Marrow Transplantation
TransplantationHematology
2015English

Minimal Residual Disease Assessment in the Context of Multiple Myeloma Treatment

Current Hematologic Malignancy Reports
Cancer ResearchOncologyHematology
2016English

Prognostic Factors and Outcome in Relapsed Multiple Myeloma After Nonmyeloablative Allo-Sct: A Single Center Experience

Bone Marrow Transplantation
TransplantationHematology
2010English

Do Cytogenetics Predict Likelihood to Attain Minimal Residual Disease (MRD) Post Autologous Stem Cell Transplantation (SCT) in Multiple Myeloma (MM)?

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Comparative Analysis of Minimal Residual Disease Detection Using Four-Color Flow Cytometry, Consensus IgH-PCR, and Quantitative IgH PCR in CLL After Allogeneic and Autologous Stem Cell Transplantation

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2004English

Association of Minimal Residual Disease With Superior Survival Outcomes in Patients With Multiple Myeloma

JAMA Oncology
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy